Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Anderson

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Translational Oncology|March 7, 2022
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinomaNonkululeko Z Malinga, Shalete C Siwele, Helen C Steel, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro StudyAnnette J Theron, Ronald Anderson, Morris Madzime, et al.
Frontiers in Immunology|June 9, 2022
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint MoleculesBernardo L Rapoport, Helen C Steel, Nomsa Hlatshwayo, et al.
Frontiers in Oncology|April 17, 2023
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3Bernardo L Rapoport, Helen C Steel, Carol A Benn, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2024
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South AfricaMieke A van der Mescht, Zelda de Beer, Helen C Steel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in miceRahul Kumar Verma, Willem A Germishuizen, M Portia Motheo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Translational Oncology|March 7, 2022
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinomaNonkululeko Z Malinga, Shalete C Siwele, Helen C Steel, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro StudyAnnette J Theron, Ronald Anderson, Morris Madzime, et al.
Frontiers in Immunology|June 9, 2022
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint MoleculesBernardo L Rapoport, Helen C Steel, Nomsa Hlatshwayo, et al.
Frontiers in Oncology|April 17, 2023
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3Bernardo L Rapoport, Helen C Steel, Carol A Benn, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2024
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South AfricaMieke A van der Mescht, Zelda de Beer, Helen C Steel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in miceRahul Kumar Verma, Willem A Germishuizen, M Portia Motheo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Pageof 18